Cooper Companies, Inc. (The) (NYSE:COO) issued an update on its fourth quarter earnings guidance on Thursday morning. The company provided earnings per share guidance of $2.60-2.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.63. The company issued revenue guidance of $552-565 million, compared to the consensus revenue estimate of $555.42 million.Cooper Companies, Inc. (The) also updated its FY17 guidance to $9.66-9.76 EPS.
Several research firms have commented on COO. Jefferies Group LLC reaffirmed a buy rating and set a $250.00 price target on shares of Cooper Companies, Inc. (The) in a research report on Tuesday. Stephens reaffirmed an equal weight rating and set a $250.00 price target (up previously from $235.00) on shares of Cooper Companies, Inc. (The) in a research report on Tuesday. Oppenheimer Holdings, Inc. reaffirmed a hold rating and set a $250.00 price target on shares of Cooper Companies, Inc. (The) in a research report on Tuesday. Robert W. Baird reaffirmed a buy rating and set a $273.00 price target (up previously from $267.00) on shares of Cooper Companies, Inc. (The) in a research report on Tuesday. Finally, J P Morgan Chase & Co reaffirmed a hold rating and set a $235.00 price target on shares of Cooper Companies, Inc. (The) in a research report on Tuesday. Six research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of $257.60.
Cooper Companies, Inc. (NYSE COO) traded down 0.419% during mid-day trading on Friday, reaching $246.005. The company’s stock had a trading volume of 152,529 shares. The firm’s 50 day moving average price is $245.27 and its 200 day moving average price is $224.26. The firm has a market capitalization of $12.02 billion, a P/E ratio of 36.882 and a beta of 0.59. Cooper Companies, Inc. has a 52 week low of $158.73 and a 52 week high of $256.39.
Cooper Companies, Inc. (The) (NYSE:COO) last posted its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, topping the Zacks’ consensus estimate of $2.58 by $0.06. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The company had revenue of $556.00 million during the quarter, compared to the consensus estimate of $552.32 million. During the same period in the prior year, the business posted $2.30 EPS. The company’s quarterly revenue was up 8.0% on a year-over-year basis. On average, analysts anticipate that Cooper Companies, Inc. will post $9.72 EPS for the current fiscal year.
In related news, VP Randal Golden sold 1,621 shares of the firm’s stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total value of $394,956.65. Following the completion of the sale, the vice president now directly owns 1,731 shares in the company, valued at approximately $421,758.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel G. Mcbride sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, June 21st. The shares were sold at an average price of $244.23, for a total transaction of $1,465,380.00. Following the completion of the sale, the chief operating officer now owns 34,395 shares of the company’s stock, valued at $8,400,290.85. The disclosure for this sale can be found here. Insiders sold a total of 20,992 shares of company stock valued at $5,167,628 over the last quarter. 1.60% of the stock is currently owned by company insiders.
WARNING: “Cooper Companies, Inc. (The) (NYSE:COO) Releases Q4 Earnings Guidance” was published by BBNS and is the property of of BBNS. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://baseballnewssource.com/markets/cooper-companies-inc-the-coo-issues-q4-earnings-guidance/1565199.html.
About Cooper Companies, Inc. (The)
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with our FREE daily email newsletter.